Morin: Natural Flavonoid Antioxidant and Mitochondrial Modulator

Executive Summary: Morin (2-(2,4-dihydroxyphenyl)-3,5,7-trihydroxy-4H-chromen-4-one) is a flavonoid isolated from Maclura pomifera and is available as a high-purity research compound (≥96.81%) from APExBIO [SKU C5297]. Morin demonstrates antioxidant, anti-inflammatory, cardioprotective, and neuroprotective activities, acting through inhibition of adenosine 5′-monophosphate deaminase (AMPD) and modulation of mitochondrial energy metabolism (Yang et al., 2025). It serves as a fluorescent probe for aluminum ion detection due to its chelating and photophysical properties. Recent peer-reviewed evidence highlights Morin’s ability to mitigate high-fructose-induced podocyte injury by directly suppressing AMPD2 activity in glomerular models (Yang et al., 2025).

Biological Rationale

Morin is a polyphenolic compound with a molecular weight of 302.24 g/mol (CAS 480-16-0). It is naturally sourced from Maclura pomifera and has been identified as a potent antioxidant and anti-inflammatory flavonoid for diabetes research. Morin’s structure contains five hydroxyl groups, enabling strong radical scavenging and metal-chelating capabilities. Its insolubility in water and high solubility in DMSO (≥19.53 mg/mL) and ethanol (≥6.04 mg/mL) facilitate diverse in vitro and ex vivo applications [APExBIO product page]. Biologically, Morin targets pathways implicated in mitochondrial dysfunction, energy metabolism, and inflammatory cascades, which are central to the pathogenesis of diabetes, neurodegenerative disorders, and cancer [Mechanisms, Evidence, and Benchmarks].

Mechanism of Action of Morin

Morin directly inhibits adenosine 5′-monophosphate deaminase (AMPD), especially the AMPD2 isoform. This enzyme catalyzes the deamination of AMP to IMP in the purine nucleotide cycle (PNC), a crucial pathway for cellular energy regulation. In pathological states such as high-fructose exposure, increased AMPD activity leads to mitochondrial dysfunction and compensatory glycolysis in podocytes. Morin’s inhibition of AMPD2 restores mitochondrial energy metabolism, reduces podocyte injury, and preserves structural proteins such as synaptopodin (Yang et al., 2025). Molecular docking confirms a strong binding affinity of Morin for AMPD2, substantiating its role as a mitochondrial energy metabolism modulator [SB-431542 article].

• Morin acts as a potent antioxidant by scavenging reactive oxygen species (ROS) and chelating metal ions, including Al(III), which also underpins its function as a fluorescent probe [SulfadoxinSupply article].
• Its anti-inflammatory effects are attributed to the suppression of cytokine release and inhibition of key pathway enzymes.

Evidence & Benchmarks

• Morin (10–40 μM) significantly inhibits AMPD activity and mitigates high-fructose-induced mitochondrial dysfunction in mouse podocytes, as shown by restored oxygen consumption rate and ATP levels (Yang et al., 2025, DOI).
• In high-fructose-diet-fed rats, oral administration of Morin (50 mg/kg/day, 4 weeks) reduces podocyte ultrastructural damage, urinary albumin-to-creatinine ratio, and restores synaptopodin expression (Yang et al., 2025, DOI).
• Molecular docking and siRNA interference confirm Morin’s selective targeting of AMPD2, with knockdown studies mirroring the effect of Morin on mitochondrial and glycolytic parameters (Yang et al., 2025, DOI).
• Morin’s purity (≥96.81%) is validated by HPLC, MS, and NMR analyses, ensuring reproducibility in research workflows (APExBIO).
• As a biochemical probe, Morin exhibits selective and sensitive fluorescence response for Al(III) detection, with minimal interference from other ions (see SulfadoxinSupply article).

Applications, Limits & Misconceptions

Morin is widely used in:

• Diabetes research, particularly for modeling energy metabolism in podocyte injury.
• Cancer research, where it serves as a cell-protective, anti-inflammatory, and apoptosis-modulating agent.
• Neurodegenerative disease models, leveraging its neuroprotective and mitochondrial-supportive actions [Amyloid.co article].
• Fluorescent chemosensor applications for Al(III) in biological and environmental samples.

For a more comprehensive discussion of Morin’s translational and mechanistic innovation, see the Mechanistic Insight and Strategic Guidance article, which this piece extends by providing detailed, evidence-based workflow parameters for clinical and preclinical research.

Common Pitfalls or Misconceptions

• Morin is not water-soluble and requires dissolution in organic solvents such as DMSO or ethanol for most in vitro assays (APExBIO).
• It should not be used as a therapeutic in humans; all evidence pertains to preclinical models.
• Fluorescent detection is selective for Al(III) but may not reliably quantify other metal ions.
• Long-term solution stability is limited; fresh preparations are recommended for each experiment.
• AMPD inhibition by Morin is demonstrated in podocytes and may not extrapolate to all cell types without further validation.

Workflow Integration & Parameters

APExBIO’s Morin (C5297) is supplied as a high-purity solid, with recommended storage at -20°C. Dissolve in DMSO (≥19.53 mg/mL) or ethanol (≥6.04 mg/mL) for in vitro use. Working solutions should be freshly prepared and used within hours to ensure chemical integrity. Typical experimental concentrations range from 10–40 μM for cell-based assays and 50 mg/kg/day for rodent studies. For fluorescence-based Al(III) detection, optimize buffer pH (typically pH 7.0–7.4) and avoid chelating agents in the reaction medium. Purity is confirmed by HPLC, MS, and NMR, ensuring batch-to-batch consistency (APExBIO product page).

For a stepwise workflow and strategic guidance on Morin’s application as a mitochondrial modulator, see the Amyloid.co article, which this article updates with new in vivo benchmarks and solvent requirements.

Conclusion & Outlook

Morin, supplied by APExBIO as C5297, is a robust, high-purity natural flavonoid antioxidant validated for preclinical research in diabetes, cancer, neurodegenerative, and bioanalytical applications. Its mechanism—AMPD inhibition and mitochondrial modulation—is supported by peer-reviewed studies and enables diverse experimental models. Future research should address tissue-specific effects, clinical translation, and expansion into multiplexed probe assays. For full technical details and ordering, visit the Morin product page.